183 related articles for article (PubMed ID: 16299828)
1. Pharmacokinetics of lactone, carboxylate and total 9-nitrocamptothecin with different doses and administration routes in rats.
Chen J; Ping Q; Guo J; Chu X; Song M
Biopharm Drug Dispos; 2006 Mar; 27(2):53-9. PubMed ID: 16299828
[TBL] [Abstract][Full Text] [Related]
2. Effect of injection routes on pharmacokinetics and lactone/carboxylate equilibrium of 9-Nitrocamptothecin in rats.
Chen J; Ping Q; Guo J; Liu M; Cai B
Int J Pharm; 2007 Aug; 340(1-2):29-33. PubMed ID: 17446016
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of 9-nitro-20(S)-camptothecin in rats.
Zhong DF; Li K; Xu JH; Du Y; Zhang YF
Acta Pharmacol Sin; 2003 Mar; 24(3):256-62. PubMed ID: 12617776
[TBL] [Abstract][Full Text] [Related]
4. [In vitro and in vivo stability of 9-nitrocamptothecin lactone form in rats].
Chen J; Ping QN; Guo JX; Liu L; Chu XZ; Song MM
Yao Xue Xue Bao; 2005 Oct; 40(10):888-92. PubMed ID: 16408803
[TBL] [Abstract][Full Text] [Related]
5. Antitumor efficacy, toxicity and pharmacokinetics of 9-nitrocamptothecin: role of lactone ratio.
Chen J; Hu RR; Yang XX; Gu W; Tian R; Gong F; Luo L; Fang F; Chen ZP; Cai BC
Cancer Chemother Pharmacol; 2013 Oct; 72(4):925-9. PubMed ID: 23934323
[TBL] [Abstract][Full Text] [Related]
6. Urinary and biliary disposition of the lactone and carboxylate forms of 20(S)-camptothecin in rats.
Scott DO; Bindra DS; Sutton SC; Stella VJ
Drug Metab Dispos; 1994; 22(3):438-42. PubMed ID: 8070321
[TBL] [Abstract][Full Text] [Related]
7. Lactone stability and tissue distribution of free and liposomal encapsulated 9-nitrocamptothecin in rats following intravenous injection.
Chen J; Cai B; Ping Q; Liu M; Guo J
Drug Dev Ind Pharm; 2008 Aug; 34(8):853-9. PubMed ID: 18686092
[TBL] [Abstract][Full Text] [Related]
8. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR
Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
[TBL] [Abstract][Full Text] [Related]
9. 9-nitrocamptothecin polymeric nanoparticles: cytotoxicity and pharmacokinetic studies of lactone and total forms of drug in rats.
Dadashzadeh S; Derakhshandeh K; Shirazi FH
Anticancer Drugs; 2008 Sep; 19(8):805-11. PubMed ID: 18690092
[TBL] [Abstract][Full Text] [Related]
10. A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors.
Yan Z; Zhu Z; Li K; Chen P; Wang L; Huang C; Xue J; Liu M
Cancer Chemother Pharmacol; 2011 Apr; 67(4):955-61. PubMed ID: 21191594
[TBL] [Abstract][Full Text] [Related]
11. Liquid chromatographic quantitation of the lactone and the total of lactone and carboxylate forms of 9-nitrocamptothecin in human plasma.
Derakhshandeh K; Dadashzadeh S
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):199-204. PubMed ID: 15734159
[TBL] [Abstract][Full Text] [Related]
12. Self-microemulsifying drug delivery system (SMEDDS) improves anticancer effect of oral 9-nitrocamptothecin on human cancer xenografts in nude mice.
Lu JL; Wang JC; Zhao SX; Liu XY; Zhao H; Zhang X; Zhou SF; Zhang Q
Eur J Pharm Biopharm; 2008 Aug; 69(3):899-907. PubMed ID: 18434109
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, tissue distribution, and the lactone/carboxylate equilibrium of hydroxycamptothecin delivered via aerosol in mice.
Hu W; Zhang C; Hu W; Fang Y; Hou W
Fitoterapia; 2012 Oct; 83(7):1291-8. PubMed ID: 22858157
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and bioavailability of oral 9-aminocamptothecin capsules in adult patients with solid tumors.
Sparreboom A; de Jonge MJ; Punt CJ; Nooter K; Loos WJ; Porro MG; Verweij J
Clin Cancer Res; 1998 Aug; 4(8):1915-9. PubMed ID: 9717819
[TBL] [Abstract][Full Text] [Related]
15. Single dose pharmacokinetics and bioavailability of glucosamine in the rat.
Aghazadeh-Habashi A; Sattari S; Pasutto F; Jamali F
J Pharm Pharm Sci; 2002; 5(2):181-4. PubMed ID: 12207871
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics and conversion of the lactone to the carboxylate forms of ginkgolide B in rat plasma.
Wang DL; Peng DY; Tao XH; Cao Y; Chen WD; Liang Y; Xie L; Liu XD
J Asian Nat Prod Res; 2013; 15(4):337-43. PubMed ID: 23421864
[TBL] [Abstract][Full Text] [Related]
17. Modified lactone/carboxylate salt equilibria in vivo by liposomal delivery of 9-nitro-camptothecin.
Chow DS; Gong L; Wolfe MD; Giovanella BC
Ann N Y Acad Sci; 2000; 922():164-74. PubMed ID: 11193891
[TBL] [Abstract][Full Text] [Related]
18. Complex of 9-nitro-camptothecin in hydroxypropyl-beta-cyclodextrin: in vitro and in vivo evaluation.
Jiang Y; Sha X; Zhang W; Fang X
Int J Pharm; 2010 Sep; 397(1-2):116-21. PubMed ID: 20637848
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of the lactone and carboxylate forms of irinotecan (CPT-11) and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in the rat.
Yang X; Hu Z; Chan SY; Goh BC; Duan W; Chan E; Zhou S
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jul; 821(2):221-8. PubMed ID: 15936253
[TBL] [Abstract][Full Text] [Related]
20. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
